INVESTMENT
IN YOUR PROFESSIONAL GROWTH
Unlock New Avenues of Professional and Financial Growth with ErgoSuture.
WHY SURGEON-INVESTORS
CHOOSE ERGOSUTURE
INVESTMENT
THE SUTURING SOLUTION
Lorem ipsum dolor sit amet consectetur adipiscing consectetur adipiscing.
Lorem ipsum dolor sit amet consectetur adipiscing consectetur adipiscing. Lorem ipsum dolor sit amet consectetur adipiscing consectetur adipiscing.
A MARKET READY FOR DISRUPTION:
THE UNTAPPED POTENTIAL OF ROLLER-BASED SUTURING
WHY ERGOSUTURE IS POSITIONED TO LEAD IN A $5.5 BILLION MARKET
CURRENT INVESTMENT
ROUND & PROCEEDS
DRIVE’N ROLL™
Laparoscopic Handheld Device (5mm Distal End):.
The Drive'N Roll is the first modular suturing system designed to decrease needle handling time, while offering a much shorter learning curve than other advanced needle drivers.
It offers advanced suturing capabilities with the simplicity of regular needle drivers. The device enhances the users’ proficiency and suturing capabilities without requiring lengthy device-specific training, regardless of Surgeons’ current Laparoscopic suturing skills or experience.
It does so through easier needle handling, cutting down the number of steps needed to perform various suturing tasks, thus reducing overall suturing time and Surgeon stress and fatigue.
PATENTS
5 US PATENTS ISSUED
3 US & 7 INTERNATIONAL PATENTS PENDING
2 NEW PROVISIONAL PATENTs
ERGOSUTURE RBS TECHNOLOGY
FUTURE GOLD STANDARD IN SUTURING
IN SOFT-TISSUE MINIMALLY INVASIVE SURGERY (MIS)
BEYOND HANDHELD DEVICES
ERGOSUTURE
FUTURE MVP FOR
ROBOT-ASSISTED SURGERY MARKET
Drive’N Roll End-Effector - Product Attributes & Benefits
X-NEEDLE
Our proprietary X-Needle addresses various suturing pain-points such as; less required needle manipulation when inserting the needle through the port.
The flexible needle extension enables easier intracorporeal knot tying. With the tapered end, we minimize tissue trauma when the needle must be backtracked from tissue if the needle was mistakenly driven past the solid portion.
The X-needle allows easier suturing in hard-to-reach locations (e.g., hernia repair).
PATENTS
3 US PATENTS APPLICATIONS
1 PCT PATENT APPLICATIONS
RBS IN CARDIOLOGY
By combining the RBS-Platform with the X-Needle, we aim to bring to market the first-ever suture-based Transcatheter suture system, which can be applied to treat high-risk patients suffering from Mitral and Tricuspid Valve Regurgitation (MVR & TVR).
Most patients suffering from Mitral or Tricuspid valve regurgitation have co-morbidities and are not eligible for surgical treatment, resulting in less than 1% of these patients benefiting from surgical care.
A new procedure called TMVR (Transcatheter Mitral Valve Repair) treatment is promising but relies on helical anchors to secure the implants, which have proven to disengage and dislodge.
BEYOND 2027...
Reliable and Effective Transcatheter Mitral Valve Repair (TMVR) Solutions will Generate Adoption and Growth Similar to the One Observed in Transcatheter Aortic Valve Repair (TAVR)
LAPAROSCOPIC SURGERY
UNMET NEEDS
DRIVE’N ROLL™
DESIGNED TO CLOSE THE SKILL GAP IN LAPAROSCOPIC SURGERY
LEARNING CURVE & EASE OF USE
Better ergonomic and simplicity of a traditional needle driver handle promotes familiarity and expands on a surgeon’s muscle memory and technique.
2025 LAUNCH OF DRIVE’N ROLL TM™
5MM HANDHELD DEVICE
DRIVE’N ROLL™ TM END-EFFECTORS
5MM HANDHELD DEVICE
ILLUSTRATION OF
DRIVE’N ROLL END-EFFECTOR
ILLUSTRATION OF ENDOLUMINAL DRIVE’N ROLL END-EFFECTOR
COMPETENTIVE OVERVIEW
MANAGMENT
TEAM
Claude Nogard
CEO & Co-Founder
Scott Seligman
CTO - Chief
Technology Officer
JONAS THELIN
Chief Operating Officer
Marc Schoutens
General Manager
EU & UK
Raymond Frame
General Manager
US
BOARD
MEMBERS
Claude Nogard
CEO & Co-Founder
Carrie Nikitin
Board Member
Eric Halioua
Board Member
SURGEON
ADVISORS
Luis Almodovar
Co-Founder & Surgical Advisor
Marcio Scorsin
surgical advisor
Dmitry Nepomnayshy
surgical advisor
ERGOSUTURE TEAM
STRONG TRACK RECORD, KNOWLEDGE, AND EXPERIENCE IN THE OPERATING ROOM FROM THE CLIENT AND SALES SIDE!
Experienced team backed by a deep bench of business advisors
With a unique blend of experience and innovation in healthcare
dedicated to the operating room
Founded a dozen startups with multiple exits
Raised more than $200M
200+ years of experience in surgical care, management, marketing, strategic planning, finance and sales in advanced surgical procedure selling and training
75+ years of experience in Pharma & Biotech
75+ years of experience in MedTech
50+ years of experience in advanced surgical procedure selling
A FLEXIBLE BUSINESS MODEL
TO FUEL ERGOSUTURE GROWTH
WHY ERGOSUTURE WILL SUCCEED
FINANCIAL HIGHLIGHTS
(UPDATED MAY 31, 2023)
2023-2027 INVESTMENT PATH
REVENUE/ EBITDA & PROJECTED ROI
CURRENT INVESTMENT
ROUND & PROCEEDS
ADRESS:
176 FEDERAL ST BOSTON,
MASSACHUSETTS 02110, US
MAIL:
INFO@ERGOSUTURE.COM
CALL TOOL-FREE TODAY
PHONE:
1-866-473-9204
